Back to Results
First PageMeta Content
Pharmacology / Dendreon / Docetaxel / Immunotherapy / Clinical trial / Nicholas J. Vogelzang / Medicine / Cancer treatments / Prostate cancer


MEDICAL OFFICER’S REVIEW MEMORANDUM
Add to Reading List

Open Document

File Size: 35,12 KB

Share Result on Facebook

Company

Dendreon / Proposed Use Dendreon Corporation / /

Event

FDA Phase / /

IndustryTerm

manufacturing / treatment of metastatic hormone refractory prostate cancer / /

MedicalCondition

metastatic prostate cancer / disease / refractory prostate cancer / prostate cancer / /

MedicalTreatment

leukapheresis / immunotherapy / /

MusicGroup

Ph.D. / /

Organization

FDA / office of Oncology Drug Products / /

Person

Steven Oh / Celia M. Witten / Craig Zinderman / M.D. Pharmacovigilance Faith Barash / Chaohong Fan / Syed Husain / Peter Bross / Lori Tull / Malcolm Moos / M.D. Boguang Zhen / Wilson W. Bryan / Bindu George / Nonclinical Reviewer Yongjie Zhou / Thomas Finn / /

Position

physician / Clinical Team Leader Biostatistician / Director Office / Clinical Branch Chief / Office Director / /

Product

D9902B / D9901 / Provenge® / D9902A / /

Technology

drug development / /

SocialTag